Title
Category
Credits
Event date
Cost
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session introduces the fundamentals of DXA technology and its role in osteoporosis screening and diagnosis. It covers best practices for accurate interpretation, highlights limitations, and explores complementary tools and techniques to assess fracture risk beyond bone mineral density.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session explores strategies for evaluating, improving, and sustaining a successful Fracture Liaison Service (FLS) program. It covers essential components such as baseline audits, business planning, multidisciplinary collaboration, and key performance indicators to support long-term program effectiveness and growth.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session covers the essential role of exercise in promoting bone health and preventing falls across the lifespan. It provides guidance on evidence-based exercise prescriptions, post-fracture management, and safe movement strategies for individuals with osteoporosis.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session explores the daily responsibilities and critical role of the Fracture Liaison Service (FLS) Coordinator in improving post-fracture care. Participants will gain insight into care pathways, risk stratification, and strategies to overcome common challenges in establishing and maintaining an effective FLS program.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
Osteoporosis 101 provides a foundational overview of osteoporosis, including its definition, epidemiology, risk factors, and individualized treatment approaches. This session also explores patient assessment strategies and evidence-based interventions to reduce fracture risk and improve outcomes.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session explores the complex biological, clinical, and endocrine factors contributing to fracture nonunion. It highlights evidence-based strategies—including endocrine evaluation, nutritional optimization, and anabolic therapies—to enhance healing outcomes through a multidisciplinary approach to care.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session focuses on optimizing bone health in patients with chronic kidney disease (CKD), highlighting the distinction between osteoporosis and renal osteodystrophy. It presents a patient-centered framework for assessing fracture risk, managing mineral metabolism, and selecting safe, effective bone-targeted therapies tailored to CKD stage and bone phenotype.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session reviews the side effects of commonly prescribed osteoporosis medications and offers practical strategies for managing patient concerns. It emphasizes personalized care, risk-benefit discussions, and approaches to modifying or switching treatments in response to adverse effects.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session explores how effective, patient-centered communication can improve the management of fracture risk in individuals with osteoporosis. It covers strategies for addressing health literacy, navigating barriers, and using shared decision-making tools to build trust, personalize care, and enhance treatment adherence.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session examines the impact of gender-affirming medical care on bone health in transgender and gender diverse (TGD) youth. It reviews skeletal development during puberty, the effects of puberty blockers and hormone therapy on bone density, and emerging research on long-term outcomes and fracture risk.

Pages